A recent clinical trial found that low-dose hydrocortisone treatment significantly improves attention and learning capabilities in women living with HIV.
The study suggests that hormonal intervention could address cognitive deficits often associated with chronic HIV infection and its long-term treatment regimens.
Researchers are now calling for larger-scale studies to determine the long-term safety and efficacy of this approach in diverse patient populations.